• Complement Component C4
  • Hydroxyzine, Urine
  • Immunophenotypic Analysis of Tissues by Flow Cytometry
  • Flecainide, Serum
  • Bacterial Culture, Blood
  • Histamine, Plasma
  • PRSS1 Gene Mutation Analysis
  • Maternal Screening, Sequential
  • Coagulation Factor IX Activity Assay, Plasma
  • Cytomegalovirus (CMV) DNA by Molecular, Qualitative or Quantitative
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Duchenne/Becker Muscular Dystrophy (DMD) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Duchenne/Becker Muscular Dystrophy (DMD) Gene Mutation Analysis
Medical Test

Turnaround Time
Access to Duchenne/Becker Muscular Dystrophy (DMD) Gene Mutation Analysis is restricted.